Full Text View
Tabular View
No Study Results Posted
Related Studies
Transtympanic Ringer's Lactate for the Prevention of Cisplatin Ototoxicity
The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2010 by McGill University Health Center.
Recruitment status was  Recruiting
Study NCT01108601   Information provided by McGill University Health Center

First Received on April 1, 2010.   Last Updated on April 20, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hearing Loss
Additional conditions recognized in this trial
Deafness
More general conditions related to this trial
Ear Diseases
Hearing Disorders
Nervous System Diseases
Neurologic Manifestations
Otorhinolaryngologic Diseases
Sensation Disorders
Signs and Symptoms
Additional drug interventions recognized in this trial
Ciprofloxacin
Cisplatin
More general drug interventions related to this trial
Anti-Infective Agents
Antineoplastic Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Nucleic Acid Synthesis Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Radiation-Sensitizing Agents
Therapeutic Uses
Sponsors listed in this trial
McGill University Health Center


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services